HOLX
Hologic, Inc.
Healthcare · United States · Stock
Historical Issuer — No Longer Independently Traded
Hologic, Inc. was acquired by Blackstone Inc. and TPG Global, LLC (affiliated investment funds) on 2026-04-07. The ticker HOLX is retired; shares of the combined entity no longer trade under this symbol.
This is a historical research profile. The company is no longer an independent public issuer and no current investment score is available.
Score breakdown not yet available
This security is being rebuilt on our SEC EDGAR filings-based scoring model. A full score breakdown will appear once the v2 pipeline covers this ticker.
Company Overview
Hologic, Inc. was a publicly traded medical technology company focused on women's health. Its common stock traded on the Nasdaq Stock Market under the ticker symbol HOLX. On April 7, 2026, Hologic announced the completion of its acquisition by funds managed by Blackstone Inc. and TPG Global, LLC, in a transaction valued at up to $79 per share, with significant minority investments from a subsidiary of the Abu Dhabi Investment Authority and an affiliate of GIC. Following the transaction, Hologic became a private company; Joe Almeida was named Chief Executive Officer at that time. Hologic's principal executive offices were located at 250 Campus Drive, Marlborough, Massachusetts, per its own SEC filing.
Business Segments
Per Hologic's own official transaction announcement, the acquisition was structured as a merger under an Agreement and Plan of Merger dated October 21, 2025, in which a Blackstone/TPG-affiliated merger subsidiary merged into Hologic, with Hologic surviving as a wholly owned subsidiary of the acquiring parent. Hologic's own site organized its historical product lines under women's health categories including Breast Health, Gynecological Health, Sexual Health, Body Composition, and Skeletal Health, alongside a Lab Technologies division covering diagnostic tests, cytology, molecular diagnostics, and screening technologies.
Principal Risks
Hologic, Inc. is no longer an independent, currently-traded public issuer. Per its own SEC Form 8-K filed April 7, 2026, the company notified Nasdaq of the merger's completion and requested that Nasdaq file a Form 25 to delist and deregister its common stock under Section 12(b) of the Securities Exchange Act; Hologic also stated its intent to subsequently file a Form 15 terminating its registration under Section 12(g) and suspending its Exchange Act reporting obligations. This page describes historical fact only and does not reflect the current financial position or operations of the private company resulting from the merger.
Source Documents
- Blackstone and TPG Complete Acquisition of Hologic — Hologic, Inc. (2026-04-07)
- Hologic, Inc. — Form 8-K, Current Report (April 7, 2026) — Hologic, Inc. (SEC-filed) (2026-04-07)
- Live re-verification via edgar_audit.py of SEC EDGAR CIK 0000859737 — U.S. Securities and Exchange Commission — EDGAR (2026-04-17)
Coverage Limitations
Hologic, Inc. (HOLX) is no longer an independent public issuer as of April 7, 2026. This page presents historical research only and does not reflect the current financial position or operations of the private company now owned by Blackstone- and TPG-affiliated funds. This historical profile does not constitute investment advice or a recommendation, and no quantitative fundamentals score is available for this ticker. This page is pending manual source/evidence review and is not indexed.
This report is for educational and research purposes only. It does not constitute financial, investment, legal, or tax advice — always conduct your own due diligence before making investment decisions.